OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
A Simple Overview of Pancreatic Cancer Treatment for Clinical Oncologists
Ingrid Garajová, Marianna Peroni, Fabio Gelsomino, et al.
Current Oncology (2023) Vol. 30, Iss. 11, pp. 9587-9601
Open Access | Times Cited: 15
Ingrid Garajová, Marianna Peroni, Fabio Gelsomino, et al.
Current Oncology (2023) Vol. 30, Iss. 11, pp. 9587-9601
Open Access | Times Cited: 15
Showing 15 citing articles:
Liposomal Irinotecan: A Review as First-Line Therapy in Metastatic Pancreatic Adenocarcinoma
Michael B. Brown, Hannah A. Blair
Drugs (2025)
Open Access
Michael B. Brown, Hannah A. Blair
Drugs (2025)
Open Access
Detection of mutated KRAS, TP53, CDK2A, and SMAD4 in tumor cell-free DNA of Brazilian pancreatic adenocarcinoma patients using next-generation sequencing
Anelis Maria Marin, Branca Engel Timoner, Diogo Dias Araújo, et al.
Research Square (Research Square) (2025)
Open Access
Anelis Maria Marin, Branca Engel Timoner, Diogo Dias Araújo, et al.
Research Square (Research Square) (2025)
Open Access
Berberine loaded glyceryl monooleate nanoparticles exhibited potent intrinsic anticancer activity against pancreatic cancer therapy: In vitro and in silico studies
Md. Harun Al Rashid, Sweta Mishra, Saswati Pattnaik, et al.
Nano Trends (2025), pp. 100092-100092
Open Access
Md. Harun Al Rashid, Sweta Mishra, Saswati Pattnaik, et al.
Nano Trends (2025), pp. 100092-100092
Open Access
Exploring radiation resistance-related genes in pancreatic cancer and their impact on patient prognosis and treatment
Dong Dai, Sen Wang, J. Li, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Dong Dai, Sen Wang, J. Li, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Impact of Surgical Resection After Induction Gemcitabine Plus S-1-Based Chemoradiotherapy in Patients with Locally Advanced Pancreatic Ductal Adenocarcinoma: A Focus on UR-LA Cases
Masashi Kishiwada, Shugo Mizuno, Aoi Hayasaki, et al.
Cancers (2025) Vol. 17, Iss. 6, pp. 1048-1048
Open Access
Masashi Kishiwada, Shugo Mizuno, Aoi Hayasaki, et al.
Cancers (2025) Vol. 17, Iss. 6, pp. 1048-1048
Open Access
Emerging role of deubiquitinases in modulating cancer chemoresistance
Sukeerthi Dasharathy, Pranay, Santhosh K Devdas, et al.
Drug Discovery Today (2025), pp. 104339-104339
Closed Access
Sukeerthi Dasharathy, Pranay, Santhosh K Devdas, et al.
Drug Discovery Today (2025), pp. 104339-104339
Closed Access
Focus on Pancreatic Cancer Microenvironment
Fabiana Pratticò, Ingrid Garajová
Current Oncology (2024) Vol. 31, Iss. 8, pp. 4241-4260
Open Access | Times Cited: 3
Fabiana Pratticò, Ingrid Garajová
Current Oncology (2024) Vol. 31, Iss. 8, pp. 4241-4260
Open Access | Times Cited: 3
Modulation of PRC1 Promotes Anticancer Effects in Pancreatic Cancer
Hajin Lee, An-Na Bae, Huiseong Yang, et al.
Cancers (2024) Vol. 16, Iss. 19, pp. 3310-3310
Open Access | Times Cited: 2
Hajin Lee, An-Na Bae, Huiseong Yang, et al.
Cancers (2024) Vol. 16, Iss. 19, pp. 3310-3310
Open Access | Times Cited: 2
Race/Ethnicity, Age, Gender Disparities among Pancreatic Cancer Patients: A Study based on SEER Database
Wang Qing, Jia Xu, Shu Huang, et al.
Research Square (Research Square) (2024)
Open Access | Times Cited: 1
Wang Qing, Jia Xu, Shu Huang, et al.
Research Square (Research Square) (2024)
Open Access | Times Cited: 1
Long-Term Survival in Metastatic Pancreatic Adenocarcinoma of Intestinal Type
G. Nita, Laura Rebegea, Valentin Titus Grigorean, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 17, pp. 5034-5034
Open Access | Times Cited: 1
G. Nita, Laura Rebegea, Valentin Titus Grigorean, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 17, pp. 5034-5034
Open Access | Times Cited: 1
Fighting Pancreatic Cancer with a Vaccine-Based Winning Combination: Hope or Reality?
Silvia Brugiapaglia, Ferdinando Spagnolo, Simona Intonti, et al.
Cells (2024) Vol. 13, Iss. 18, pp. 1558-1558
Open Access | Times Cited: 1
Silvia Brugiapaglia, Ferdinando Spagnolo, Simona Intonti, et al.
Cells (2024) Vol. 13, Iss. 18, pp. 1558-1558
Open Access | Times Cited: 1
Altered Mechanobiology of PDAC Cells with Acquired Chemoresistance to Gemcitabine and Paclitaxel
Alessandro Gregori, Cecilia Bergonzini, Mjriam Capula, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Alessandro Gregori, Cecilia Bergonzini, Mjriam Capula, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Mcl-1 expression is a predictive marker of response to gemcitabine plus nab-paclitaxel for metastatic pancreatic cancer
Makiko Urabe, Kenji Ikezawa, Yusuke Seiki, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Makiko Urabe, Kenji Ikezawa, Yusuke Seiki, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Altered Mechanobiology of PDAC Cells with Acquired Chemoresistance to Gemcitabine and Paclitaxel
Alessandro Gregori, Cecilia Bergonzini, Mjriam Capula, et al.
Cancers (2024) Vol. 16, Iss. 22, pp. 3863-3863
Open Access
Alessandro Gregori, Cecilia Bergonzini, Mjriam Capula, et al.
Cancers (2024) Vol. 16, Iss. 22, pp. 3863-3863
Open Access
Development and validation of the Normalized Organoid Growth Rate (NOGR) metric in brightfield imaging-based assays
Christophe Deben, Edgar Cardenas De La Hoz, Felicia Rodrigues Fortes, et al.
Communications Biology (2024) Vol. 7, Iss. 1
Open Access
Christophe Deben, Edgar Cardenas De La Hoz, Felicia Rodrigues Fortes, et al.
Communications Biology (2024) Vol. 7, Iss. 1
Open Access
